Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling.

IF 10.6 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Diabetology Pub Date : 2026-02-22 DOI:10.1186/s12933-026-03117-z

Zuo Qi, Jie Liu, Tianshu Gu, Ning Wu, Junyu Liu, Jinhua Zhao, Gary Tse, Gregory Y H Lip, Kang-Yin Chen, Tong Liu

引用次数: 0

查看原文本刊更多论文

SGLT2抑制剂启动后的红细胞增多和房颤的抗凝结果：一个真实世界的分析与反事实模型。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Diabetology 医学-内分泌学与代谢

CiteScore

12.30

自引率

15.10%

发文量

240

审稿时长

1 months

期刊介绍： Cardiovascular Diabetology is a journal that welcomes manuscripts exploring various aspects of the relationship between diabetes, cardiovascular health, and the metabolic syndrome. We invite submissions related to clinical studies, genetic investigations, experimental research, pharmacological studies, epidemiological analyses, and molecular biology research in this field.